Back to today’s briefing

Story perspectives

Study Links HSV-1 to Alzheimer’s; Drugs Show Promise

2/26/2025

33 4

Summary

Story summary

A groundbreaking study from Cleveland Clinic's Genome Center reveals a startling connection between herpes simplex-1 (HSV-1) and Alzheimer’s disease. Researchers discovered that two FDA-approved drugs, valacyclovir and acyclovir, can reverse the disease's progression in lab tests, hinting that HSV-1 may trigger harmful changes in aging brains, leading to neurodegeneration.

1 of 1

Story summary

A groundbreaking study from Cleveland Clinic's Genome Center reveals a startling connection between herpes simplex-1 (HSV-1) and Alzheimer’s disease. Researchers discovered that two FDA-approved drugs, valacyclovir and acyclovir, can reverse the disease's progression in lab tests, hinting that HSV-1 may trigger harmful changes in aging brains, leading to neurodegeneration.